iBio, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held by iBio, Inc. on November 20, 2025. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol "IBIO."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
A total of 10,566,364 shares were represented at the meeting, establishing a quorum. Stockholders voted on four proposals with the following outcomes:
- Proposal 1 (Election of Directors): Dr. Martin Brenner and Dr. Alexandra Kropotova were elected as Class II directors for three-year terms. Dr. Brenner received 4,803,078 votes for, while Dr. Kropotova received 2,916,804 votes for.
- Proposal 2 (Auditor Ratification): Stockholders ratified the appointment of Grassi & Co., CPAs, P.C. as the independent registered public accounting firm for the fiscal year ending June 30, 2026. The vote was 9,912,837 for, 594,576 against, and 58,951 abstentions.
- Proposal 3 (Say-on-Pay): The advisory vote on executive compensation was approved with 4,392,583 votes for and 403,278 votes against.
- Proposal 4 (Frequency of Say-on-Pay): Stockholders approved conducting future advisory votes on executive compensation annually (1-year frequency). The vote was 4,290,210 for the 1-year option.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors. The company has committed to holding annual advisory votes on executive compensation in accordance with the Dodd-Frank Act until a new frequency vote is required.
Key Facts for Investor Verification
- Verify the full composition of the Board of Directors following the election of the two new Class II directors.
- Review the Definitive Proxy Statement (Schedule 14A) filed on October 6, 2025, for detailed executive compensation data referenced in Proposal 3.
- Confirm the engagement terms and scope of work with the newly ratified auditor, Grassi & Co., CPAs, P.C.
- Note the significant number of broker non-votes (5,687,668) on director elections and compensation proposals, indicating shares held in street name where brokers lacked discretionary voting power.